ReviewCardiovascular drugs and therapy2025

Reassessing Ivabradine: Potential Benefits and Risks in Atrial Fibrillation Therapy.

Dorsa Alijanzadeh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.